Daniel C. Maneval
12Patents
5h-index
27Co-inventors
66Inventor score
Filing activity: Oct 25, 1994 → Jun 16, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5932210A | Recombinant adenoviral vector and methods of use | Chemistry; Metallurgy | 58 | Expired |
| US6210939A | Recombinant adenoviral vector and methods of use | Emerging Cross-Sectional Technologies | 23 | Expired |
| US9913822B2 | Combination therapy with an anti-hyaluronan agent and therapeutic agent | Chemistry; Metallurgy | 22 | Active |
| US6165779A | Compositions and methods for therapeutic use | Chemistry; Metallurgy | 22 | Expired |
| US7157079B2 | Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms | Chemistry; Metallurgy | 22 | Expired |
| US6989268B2 | Recombinant adenoviral vector and methods of use | Emerging Cross-Sectional Technologies | 3 | Expired |
| US7462351B2 | Nucleic acid delivery | Emerging Cross-Sectional Technologies | 3 | Expired |
| US6331524A | Organ-specific targeting of cationic amphiphile / DNA complexes for gene therapy | Chemistry; Metallurgy | 1 | Expired |
| US10137104B2 | Combination therapy with an anti-hyaluronan agent and therapeutic agent | Chemistry; Metallurgy | 1 | Active |
| US7041284B2 | Recombinant adenoviral vector and method of use | Emerging Cross-Sectional Technologies | 1 | Expired |
| US7105156B1 | Method of using an adenoviral vector encoding a retinoblastoma protein to treat hyperproliferating cells | Chemistry; Metallurgy | 1 | Expired |
| US7094583B2 | Nucleic acid delivery | Emerging Cross-Sectional Technologies | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.